Abstract
Autism with co-occurring exceptional cognitive ability is often accompanied by severe internalizing symptoms and feelings of inadequacy. Whether cognitive ability also translates into greater risk for suicidal ideation is unclear. To investigate this urgent question, we examined two samples of high-ability individuals with autism for factors that were predictive of suicidal ideation. In the first sample (N=1,074 individuals seen at a clinic specializing in gifted/talented youth), we observed a striking excess of parent-reported suicidal ideation in autistic individuals with IQ≥120 (OR=5.9, p = 0.0007). In separate sample of N=1,983 SPARK participants, we confirmed higher rates of suicidal thoughts compared to non-autistic children from the ABCD cohort (OR=6.8, p < 2.2 × 10−16), and further that autistic children with suicidal thoughts had significantly higher cognitive ability (p < 2.2 × 10−16) than those without. Elevated polygenic scores (PGS) for cognitive performance were associated with increased suicidal thoughts (Z = 2.16, p = 0.03), with PGS for educational attainment trending in the same direction (Z = 1.4, p = 0.17). Notably, similar results were found in parents of these autistic youth, where higher PGS for educational attainment was associated with increasing thoughts of suicide (Z=2.28, p=0.02). Taken together, these results suggest that on a phenotypic and genetic level, increasing cognitive ability is an unexpected risk factor for suicidal ideation in individuals diagnosed with, or at risk for autism.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by a grant from the Simons Foundation (SFARI Explorer 594788 to JJM). This work was also supported by the University of Iowa Hawkeye Intellectual and Developmental Disabilities Research Center P50 HD103556 (TA and Lane Strathearn, multi-PIs). Additional funding for this work came from the Department of Psychiatry at the University of Iowa and in part by National Institutes of Health through a Predoctoral Training Grant (T32GM008629 to LC and TT) and Research Grant DC014489 to JJM.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the University of Iowa IRB (IRB 202002251). The Research Match study was approved by the University of Iowa IRB (IRB 201812788) and SPARK is approved by the Western IRB (IRB 20151664).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data from the SPARK and ABCD cohorts are available to researchers online. All data produced in the present study are available upon reasonable request to the authors following acceptance of the manuscript to a peer-reviewed journal.
